packed red blood cells before transfer to the labor and delivery ward for recovery.
The next day, the patient returned to the operating room for examination and removal of the vaginal packing. The site of the original hematoma was found to be open and was repaired with a running stitch using 3-0 Vicryl. The patient's postpartum course was otherwise unremarkable. She was advanced to a regular diet, tolerated oral pain medications, and was ambulatory at the time of discharge. She was discharged 2 days after delivery.
Postpartum retroperitoneal hemorrhage is a rare, life-threatening event characterized by bleeding from splanchnic vessels into the retroperitoneal space. Its incidence is speculative because of its rarity [2] . Postpartum retroperitoneal hemorrhage has been associated with traumatic vaginal delivery [3] , manual removal of placenta [4] , and anticoagulation [5] .
Diagnosis of retroperitoneal hemorrhage is often delayed as a result of its rarity and the lack of specific presenting signs and symptoms. Chest, back, and abdominal pain caused by retroperitoneal hemorrhage are often attributed to alternative etiologies [6] . Therefore, a high index of suspicion is necessary to make the correct diagnosis and avoid the associated morbidity and mortality.
Retroperitoneal hemorrhage should be considered as a possible etiology of persistent and localized pelvic, thoracic, back, and epigastric pain associated with a sudden drop in hematocrit. When suspected, ultrasonography is the first diagnostic test. If the suspected hemorrhage is not demonstrated, abdominal computed tomography can effectively demonstrate its presence.
Historically, retroperitoneal hemorrhages were addressed surgically. However, percutaneous arterial embolization has a higher safety index and is a more precise method to address a retroperitoneal hemorrhage in the hemodynamically stable patient [7] . Diagnostic aortography is used to localize the site of bleeding, which is visualized with extravasation of contrast from a traumatized vessel. Once the source of bleeding is located, an embolic agent is injected. Gelatin foam is a commonly used particulate embolization agent [8] , and creates a mechanical barrier to continued hemorrhage. Additionally, the cast creates a surface for thrombogenesis. Gelatin foam is a favored embolization agent because of its low cost, ease of use, and many years of clinical use.
Three cases of retroperitoneal hemorrhage following spontaneous vaginal delivery have been reported [2] . The first patient presented with subacute abdominal pain and symptoms of hypovolemic shock due to rupture of the uterine artery 3 days after delivery. The second patient had a retroperitoneal hemorrhage on the second day after delivery secondary to rupture of the right ovarian artery. In the final case, a patient presented with chest pain 1 day after delivery due to rupture of the splenic vein.
The case presented here is unique from these prior cases in two ways. Firstly, the previous cases were addressed surgically, whereas the case presented here was resolved by percutaneous arterial embolization. Notably, arterial embolization was effective, although extravasation from a hemorrhaging vessel was not identified. Secondly, the present patient's retroperitoneal hemorrhage presented as a vaginal hematoma. The prevalence of vaginal hematoma is one in every 300-1500 deliveries, and the problem most commonly arises following operative delivery or episiotomy [1] .
There is ongoing debate as to whether vaginal hematoma should be addressed conservatively or by operative management. On the basis of the case presented here, the potential discovery of a retroperitoneal hemorrhage presenting as a vaginal hematoma could favor an operative approach.
In conclusion, a worsening vaginal hematoma in the postpartum setting can be the presenting sign of a retroperitoneal hemorrhage. Percutaneous arterial embolization is an effective method of hemostasis. A high index of suspicion and early diagnosis can be lifesaving.
Cervical cancer during pregnancy represents an important challenge because of its impact on fetal development, the difficulties in the management of the disease, and the unknown final oncologic outcomes. The main factors to be considered in its management are gestational age, local extension, histological subtype, and lymph node involvement, which seems to be the most important prognostic factor [1] .
In August 2012, a woman aged 29 years presented at the Gynecologic Oncology Unit of La Paz University Hospital, Madrid, Spain, after 23 weeks of pregnancy with vaginal bleeding due to a 60-mm polypoid formation in her cervix. The formation was removed surgically, and pathologic analysis showed that it was a poorly differentiated adenocarcinoma of the cervix. Magnetic resonance imaging at 25 weeks of pregnancy showed a residual lesion measuring 16 × 9 mm, without stromal or parametrial involvement (Fig. 1) . The carcinoma was deemed to be International Federation of Gynecology and Obstetrics (FIGO) stage IB2 [2] .
A simple trachelectomy and a cervical cerclage were performed after 29 weeks of pregnancy. Pathologic assessment revealed a residual well differentiated cervical adenocarcinoma measuring 4 mm with free surgical margins. At 34 weeks of pregnancy, the cervical cerclage was
